Gene · 57142
Papers2,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Site-Specific Activity-Based Protein Profiling Using Phosphonate Handles. | Mol Cell Proteomics | 2023 | 36435334 | PubTator, text mining | PubMed |
| IFITM proteins: Understanding their diverse roles in viral infection, cancer, and immunity. | J Biol Chem | 2023 | 36435199 | PubTator, text mining | PubMed |
| Application of biomimetic surfaces and 3D culture technology to study the role of extracellular matrix interactions in neurite outgrowth and inhibition. | Biomater Adv | 2023 | 36434926 | PubTator, text mining | PubMed |
| Association of Nogo-A Gene Polymorphisms with Cerebral Palsy in Southern China: A Case-Control Study. | Dev Neurosci | 2023 | 36323241 | PubTator, text mining | PubMed |
| NG2-glia: rising stars in stress-related mental disorders? | Mol Psychiatry | 2023 | 36280754 | PubTator, text mining | PubMed |
| Clemastine in remyelination and protection of neurons and skeletal muscle after spinal cord injury. | Neural Regen Res | 2023 | 36254972 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| A cellular atlas of calcineurin signaling. | Biochim Biophys Acta Mol Cell Res | 2023 | 36191737 | PubTator, text mining | PubMed |
| MicroRNA-based targeting of the Rho/ROCK pathway in therapeutic strategies after spinal cord injury. | Neural Regen Res | 2023 | 35900410 | PubTator, text mining | PubMed |
| The potential of gene therapies for spinal cord injury repair: a systematic review and meta-analysis of pre-clinical studies. | Neural Regen Res | 2023 | 35900407 | PubTator, text mining | PubMed |
| Regulatory roles of NAT10 in airway epithelial cell function and metabolism in pathological conditions. | Cell Biol Toxicol | 2023 | 35877022 | PubTator, text mining | PubMed |
| Investigating habits in humans with a symmetrical outcome-revaluation task. | Behav Res Methods | 2023 | 35867208 | PubTator, text mining | PubMed |
| TCF7l2, a nuclear marker that labels premyelinating oligodendrocytes and promotes oligodendroglial lineage progression. | Glia | 2023 | 35841271 | PubTator, text mining | PubMed |
| Nogo-A reduces ceramide de novo biosynthesis to protect from heart failure. | Cardiovasc Res | 2023 | 35815623 | PubTator, text mining | PubMed |
| Synaptic pathology in multiple sclerosis: a role for Nogo-A signaling in astrocytes? | Neural Regen Res | 2023 | 35799527 | PubTator, text mining | PubMed |
| Molecular approaches for spinal cord injury treatment. | Neural Regen Res | 2023 | 35799504 | PubTator, text mining | PubMed |
| Dynamic induction of the myelin-associated growth inhibitor Nogo-A in perilesional plasticity regions after human spinal cord injury. | Brain Pathol | 2023 | 35698271 | PubTator, text mining | PubMed |
| Emotional Modulation of Response Inhibition in Adolescents During Acute Suicidal Crisis: Event-Related Potentials in an Emotional Go/NoGo Task. | Clin EEG Neurosci | 2023 | 34894813 | PubTator, text mining | PubMed |
| Electroacupuncture promotes nerve regeneration and functional recovery in rats with spinal cord contusion through the coordinate interaction of CD4 and BDNF. | Ibrain | 2022 | 37786738 | PubTator, text mining | PubMed |
| The role of microglia in Alzheimer's disease and progress of treatment. | Ibrain | 2022 | 37786418 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57142/papers?page=16